These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33835078)

  • 1. Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro.
    Lepczyńska M; Dzika E; Chen W; Lu CY
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00325. PubMed ID: 33835078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on
    Lepczyńska M; Dzika E
    Gut Pathog; 2019; 11():6. PubMed ID: 30815037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
    Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
    Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study.
    Pasupuleti B; Gone V; Baddam R; Venisetty RK; Prasad OP
    Curr Drug Metab; 2020; 21(2):126-131. PubMed ID: 32067615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro.
    Staines KA; Myers K; Little K; Ralston SH; Farquharson C
    Calcif Tissue Int; 2021 Dec; 109(6):696-705. PubMed ID: 34213594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.
    Abed MN; Alassaf FA; Jasim MHM; Alfahad M; Qazzaz ME
    Pharmacology; 2020; 105(11-12):645-651. PubMed ID: 32289807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole vs pantoprazole effects on cyclosporine levels in kidney transplantation: A randomized clinical trial.
    El-Bohy D; El Sharkawy M; Abo-Elazm S; Shahin S; Bchari W; Mancy A; El Hamamsy M
    Ther Apher Dial; 2020 Oct; 24(5):591-598. PubMed ID: 31856374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the "gastric barrier effect" in patients chronically treated with PPI: a pilot study.
    Del Piano M; Anderloni A; Balzarini M; Ballarè M; Carmagnola S; Montino F; Orsello M; Pagliarulo M; Tari R; Soattini L; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S18-26. PubMed ID: 22955351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compared to histamine-2 receptor antagonist, proton pump inhibitor induces stronger oral-to-gut microbial transmission and gut microbiome alterations: a randomised controlled trial.
    Zhu J; Sun C; Li M; Hu G; Zhao XM; Chen WH
    Gut; 2024 Jun; 73(7):1087-1097. PubMed ID: 38050061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of proton pump inhibitors on in vitro activity of tigecycline against several common clinical pathogens.
    Ni W; Cai X; Liang B; Cai Y; Cui J; Wang R
    PLoS One; 2014; 9(1):e86715. PubMed ID: 24466210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors alter gut microbiota by promoting oral microbiota translocation: a prospective interventional study.
    Xiao X; Zhang X; Wang J; Liu Y; Yan H; Xing X; Yang J
    Gut; 2024 Jun; 73(7):1098-1109. PubMed ID: 38267200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors versus
    Brilhante RS; da Rocha MG; de Oliveira JS; España JD; Pereira VS; Scm Castelo-Branco D; A Pereira-Neto W; Sidrim JJ; A Cordeiro R; Rocha MF
    Future Microbiol; 2019 Apr; 14():489-497. PubMed ID: 31033338
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.
    Moody DE; Liu F; Fang WB
    J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Antimicrobial Susceptibility Patterns of Blastocystis.
    Roberts T; Bush S; Ellis J; Harkness J; Stark D
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4417-23. PubMed ID: 25987633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
    Tsujimoto H; Hirata Y; Ueda Y; Kinoshita N; Tawa H; Tanaka Y; Koshiba R; Ota K; Kojima Y; Kakimoto K; Takeuchi T; Miyazaki T; Nakamura S; Higuchi K
    Eur J Clin Pharmacol; 2021 Nov; 77(11):1639-1648. PubMed ID: 34085115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse Liver.
    Assalin HB; De Almeida KCG; Guadagnini D; Santos A; Teixeira CJ; Bordin S; Rocha GZ; Saad MJA
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term acid suppression therapy with proton pump inhibitors or H
    Damodharan S; Raj GM; Sakthibalan M; Dakshinamoorthy K; Muraliswaran P
    Ir J Med Sci; 2021 Aug; 190(3):1213-1217. PubMed ID: 33085017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of esomeprazole 40 mg, rabeprazole 20 mg, lansoprazole 30 mg, and pantoprazole 40 mg on intragastrıc pH in extensive metabolizer patients with gastroesophageal reflux disease.
    Çelebi A; Aydın D; Kocaman O; Konduk BT; Şentürk Ö; Hülagü S
    Turk J Gastroenterol; 2016 Sep; 27(5):408-414. PubMed ID: 27782887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.
    Raman K; Kumar S; Chye TT
    Parasitol Res; 2016 Jan; 115(1):391-6. PubMed ID: 26481491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.